Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
ORBIMED ADVISORS LLC - 14 Apr 2026 SCHEDULE 13D/A Report for ImageneBio, Inc. COMMON STOCK (IMA)
- Filing manager
- ORBIMED ADVISORS LLC
- Reporting owner
- ORBIMED ADVISORS LLC
- Security
- ImageneBio, Inc. COMMON STOCK
- Beneficially owned shares
- 1,495,045 shares
- Large-stake signal
-
Ownership
13%Beneficial ownership of this reported class.
Shares
1,495,045 sharesShares beneficially owned as disclosed.
Event date
14 Apr 2026Date tied to the ownership event or amendment.
Accepted by SEC
29 Apr 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 13%
- Symbol
- IMA
- Shares outstanding
- 11,412,557 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 29 Apr 2026, 19:07:16 UTC
- Event date
- 14 Apr 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
ORBIMED ADVISORS LLC disclosed 13% ownership in ImageneBio, Inc. COMMON STOCK (IMA) on 14 Apr 2026.
Key facts
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for ImageneBio, Inc. COMMON STOCK (IMA).
- Disclosed ownership: 13%.
- Date of event: 14 Apr 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Apr 2026, 19:07.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 13% | 1,495,045 | 0 | 1,495,045 | /s/ Carl L. Gordon | Carl L. Gordon, Member | 0001055951 |
| ORBIMED CAPITAL GP VI LLC | 9.6% | 1,089,665 | 0 | 1,089,665 | /s/ Carl L. Gordon | Carl L. Gordon, Member of OrbiMed Advisors LLC | 0001682115 |
| OrbiMed Genesis GP LLC | 3.6% | 405,380 | 0 | 405,380 | /s/ Carl L. Gordon | Carl L. Gordon, Member of OrbiMed Advisors LLC | 0001808744 |
| ORBIMED CAPITAL LLC | 1.2% | 135,516 | 135,516 | 0 | /s/ Carl L. Gordon | Carl L. Gordon, Member | 0001157524 |
CIK / CUSIP context first